Xavier Jacq

Critic
DISC Type : C

Chief Scientific Officer at MitoRx Therapeutics

Greater Cambridge Area, United Kingdom

Overview

Xavier Jacq is the Chief Scientific Officer at MitoRx Therapeutics, leveraging extensive expertise in drug discovery, biochemistry, and molecular biology. His distinguished background includes a Ph. D. from Université Louis Pasteur, postdoctoral research at Columbia University, and multiple scientific leadership and advisory roles across the industry.

He is keenly interested in developing novel therapeutics for metabolic diseases, particularly obesity, and frequently presents new findings at major international conferences. His work also extends to AI applications in the pharmaceutical industry through his board-level involvement.

He is a co-inventor on multiple patents for novel inhibitors of cysteine proteases, designed specifically for therapeutic applications in oncology.

Personality Overview

Negotiator

Critic

Objective Thinker

It is very likely that they will negotiate pricing or other important terms.  They prefer to do logical analysis and value evidence over emotions. They enjoy working alone and do not rely on others very often.

Topics They Care About

Obesity Treatments
He recently presented his company's latest discoveries in obesity models at major conferences like EASD and ADA, showing a strong current focus on this therapeutic area.
Enzyme Inhibition
His publications and patents detail his work on deubiquitylating enzymes (DUBs) and the development of novel inhibitors for cysteine proteases for therapeutic use.
Drug Discovery
His entire career is centered on drug discovery, with specific skills in assay development, HTS, and molecular and cell biology to identify new therapeutic agents.

Media Appearances

Xavier has no verified media appearances

Work History

5-2025
Chief Scientific Officer at MitoRx Therapeutics
5-2024
Board Member-Non Executive Director at Evariste
1-2023 - 5-2025
Scientific Advisory Board Member at Ubiquigent Ltd
12-2022 - 5-2025
Chief Scientific Officer at MoA Technology
1-2022 - 12-2022
Senior Vice President at Dunad Therapeutics

Education

1997 - 2000
PostDoc from Columbia University
1993 - 1997
PhD from Université Louis Pasteur (Strasbourg I)

More Information

Social Presence :

Prographics :

Exp : 32 Location : Greater Cambridge Area, United Kingdom Job Level : Leadership Designation : Chief Scientific Officer at MitoRx Therapeutics
URL has been copied!

Insights For Selling To Xavier

During A Call Or A Meeting

DO's

  • Don’t forget to mention how you compare to competition on both features and pricing
  • Tell them what ROI they can expect
  • Be ready to answer many clarity-seeking questions and requests for information

DONT's

  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Do not use very emotional or colorful language
  • Don't give superficial answers, they are easily rattled by them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Xavier is

  • Strong evidence of ROI, effective pricing, and proven data points matter the most to them.
  • Will you ever get a clear answer from Xavier

  • It is not very hard for them to say no if they are not convinced about the decision.

Insights For Deal Planning

    How fast (or slow) will Xavier move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Xavier take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Xavier

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.